DICP OpenIR
Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome P450 3A and P-glycoprotein
Zhao, Shan; Wu, Jingjing; Zhang, Ying; Sun, Dongsheng; Liao, Han; Liu, Yang; Sun, Guangwei
Source PublicationCANCER SCIENCE
2018-12-01
ISSN1349-7006
Volume109Pages:224-224
WOS SubjectOncology
WOS Research AreaOncology
Language英语
WOS IDWOS:000453773601043
PublisherWILEY
Citation statistics
Document Type期刊论文
Identifierhttp://cas-ir.dicp.ac.cn/handle/321008/166325
Collection中国科学院大连化学物理研究所
AffiliationChinese Acad Sci, Dalian Inst Chem Phys, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Zhao, Shan,Wu, Jingjing,Zhang, Ying,et al. Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome P450 3A and P-glycoprotein[J]. CANCER SCIENCE,2018,109:224-224.
APA Zhao, Shan.,Wu, Jingjing.,Zhang, Ying.,Sun, Dongsheng.,Liao, Han.,...&Sun, Guangwei.(2018).Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome P450 3A and P-glycoprotein.CANCER SCIENCE,109,224-224.
MLA Zhao, Shan,et al."Co-administration strategy to enhance bioavailability of sorafenib by modulating cytochrome P450 3A and P-glycoprotein".CANCER SCIENCE 109(2018):224-224.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhao, Shan]'s Articles
[Wu, Jingjing]'s Articles
[Zhang, Ying]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhao, Shan]'s Articles
[Wu, Jingjing]'s Articles
[Zhang, Ying]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhao, Shan]'s Articles
[Wu, Jingjing]'s Articles
[Zhang, Ying]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.